Add to Favorites
Share

Oritavancin CAS:171099-57-3

  • Description
Product Detail


    Product Information

    CAS NO.171099-57-3 1.png
    Product NameOritavancin
    SynonymsLY 333328
    FormulaC86H97Cl3N10O26
    Molecular Weight1793.12
    Spec / Purity98%min
    Supply Capacity
    DetailsOritavancin (LY333328/Orbactiv) is a novel semisynthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive bacterial infections. In December 2008, the US FDA declined to approve it without additional studies, and an EU application was withdrawn. In 2009, the development rights were acquired by The Medicines Company, which has completed clinical trials and submitted a new drug application to the FDA in February 2014. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections in the United States. Its chemical structure is similar to vancomycin. It is a lipoglycopeptide.
Send your message to this supplier
To:  

Shanghai Biopharmaleader Co.,Ltd

* Content:  

For better quotations, include:

- A self introduction

- Special requests, if any

Quantity:  

  
You May Like
Not exactly what you want? One request, multiple quotations Get Quotations Now >>
Related Searches :